BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

682 related articles for article (PubMed ID: 17716195)

  • 1. Liposome-nanoparticle hybrids for multimodal diagnostic and therapeutic applications.
    Al-Jamal WT; Kostarelos K
    Nanomedicine (Lond); 2007 Feb; 2(1):85-98. PubMed ID: 17716195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine.
    Al-Jamal WT; Kostarelos K
    Acc Chem Res; 2011 Oct; 44(10):1094-104. PubMed ID: 21812415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted delivery of multifunctional magnetic nanoparticles.
    McCarthy JR; Kelly KA; Sun EY; Weissleder R
    Nanomedicine (Lond); 2007 Apr; 2(2):153-67. PubMed ID: 17716118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotechnology and glaucoma: a review of the potential implications of glaucoma nanomedicine.
    Kim NJ; Harris A; Gerber A; Tobe LA; Amireskandari A; Huck A; Siesky B
    Br J Ophthalmol; 2014 Apr; 98(4):427-31. PubMed ID: 24246373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface-active liposomes for targeted cancer therapy.
    Sofou S
    Nanomedicine (Lond); 2007 Oct; 2(5):711-24. PubMed ID: 17976032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functionalized-quantum-dot-liposome hybrids as multimodal nanoparticles for cancer.
    Al-Jamal WT; Al-Jamal KT; Bomans PH; Frederik PM; Kostarelos K
    Small; 2008 Sep; 4(9):1406-15. PubMed ID: 18711753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposomal drug delivery systems: from concept to clinical applications.
    Allen TM; Cullis PR
    Adv Drug Deliv Rev; 2013 Jan; 65(1):36-48. PubMed ID: 23036225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances on surface engineering of magnetic iron oxide nanoparticles and their biomedical applications.
    Gupta AK; Naregalkar RR; Vaidya VD; Gupta M
    Nanomedicine (Lond); 2007 Feb; 2(1):23-39. PubMed ID: 17716188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifunctional nanoparticles for multimodal imaging and theragnosis.
    Lee DE; Koo H; Sun IC; Ryu JH; Kim K; Kwon IC
    Chem Soc Rev; 2012 Apr; 41(7):2656-72. PubMed ID: 22189429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanomedicine and veterinary science: the reality and the practicality.
    Underwood C; van Eps AW
    Vet J; 2012 Jul; 193(1):12-23. PubMed ID: 22365842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications.
    Lee JE; Lee N; Kim T; Kim J; Hyeon T
    Acc Chem Res; 2011 Oct; 44(10):893-902. PubMed ID: 21848274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodegradable, polymeric nanoparticle delivery systems for cancer therapy.
    Pridgen EM; Langer R; Farokhzad OC
    Nanomedicine (Lond); 2007 Oct; 2(5):669-80. PubMed ID: 17976029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Properties, engineering and applications of lipid-based nanoparticle drug-delivery systems: current research and advances.
    Buse J; El-Aneed A
    Nanomedicine (Lond); 2010 Oct; 5(8):1237-60. PubMed ID: 21039200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theranostic nanoparticles engineered for clinic and pharmaceutics.
    Ma X; Zhao Y; Liang XJ
    Acc Chem Res; 2011 Oct; 44(10):1114-22. PubMed ID: 21732606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanosized multifunctional liposomes for tumor diagnosis and molecular imaging by SPECT/CT.
    Silindir M; Erdoğan S; Özer AY; Doğan AL; Tuncel M; Uğur Ö; Torchilin VP
    J Liposome Res; 2013 Mar; 23(1):20-7. PubMed ID: 23078019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
    Shapira A; Livney YD; Broxterman HJ; Assaraf YG
    Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of gold nanoparticles in biomedical and drug delivery.
    Daraee H; Eatemadi A; Abbasi E; Fekri Aval S; Kouhi M; Akbarzadeh A
    Artif Cells Nanomed Biotechnol; 2016; 44(1):410-22. PubMed ID: 25229833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetoliposomes as multimodal contrast agents for molecular imaging and cancer nanotheragnostics.
    Fattahi H; Laurent S; Liu F; Arsalani N; Vander Elst L; Muller RN
    Nanomedicine (Lond); 2011 Apr; 6(3):529-44. PubMed ID: 21542690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomes and other vesicular systems: structural characteristics, methods of preparation, and use in nanomedicine.
    Elizondo E; Moreno E; Cabrera I; Córdoba A; Sala S; Veciana J; Ventosa N
    Prog Mol Biol Transl Sci; 2011; 104():1-52. PubMed ID: 22093216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid-based nanoparticles for contrast-enhanced MRI and molecular imaging.
    Mulder WJ; Strijkers GJ; van Tilborg GA; Griffioen AW; Nicolay K
    NMR Biomed; 2006 Feb; 19(1):142-64. PubMed ID: 16450332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.